West Virginia University now officially owns the former Mylan pharmaceutical manufacturing facility, according to information released by the university Thursday afternoon.
WVU paid $1 for the facility from health care company Viatris and plans to use the facility to create “short-, medium- and long-term academic, employment and community opportunities for Morgantown and surrounding areas, as well as tuition scholarships for impacted Mylan employees.”
WVU and WVU Medicine will work together to oversee future development through a reconfigured WVU Innovation Corporation which will handle the daily operations at the facility.
“We are pleased that Viatris placed its faith and trust in West Virginia University by engaging with us in this opportunity which combines WVU’s educational, entrepreneurial and research endeavors in new ways to make a real difference in our community,” WVU Vice President forStrategic Initiatives Rob Alsop said.
Discussions are already underway with potential tenants to lease space within the 1.1 million square foot facility, according to WVU Health System President and CEO Albert Wright.
“This property holds a lot of potential for Morgantown, the region and the state,” he said.”There is already a tremendous level of pioneering research being done through the University and the WVU Health System.”
The sprawling facility has room for multiple tenants, Wright said during a press call following Thursday’s announcement.
“There is significant interest from many parties in that building. We’re going to be working up a lot of different possibilities as to how we use that building over time,” he said. “I think it’s going to look more like a shopping mall over time, with a few anchor tenants and a few smaller, other entities in there versus one bog occupant.”
There are currently no plans to remodel the facility, but that could change as tenants come on board and outline their specific needs, Wright said.
Gov. Jim Justice released a statement Thursday applauding WVU’s announcement.
“When you have a pillar of our state as well known and as successful as WVU taking over such an important facility right in their backyard, you know the results are going to be tremendous.”
U.S. Sens. Joe Manchin, D-W.Va, and Shelley Moore Capito, R-W.Va. and Rep. David McKinley, R-W.Va., also released a joint statement Thursday afternoon.
“Today’s announcement is great news for the Morgantown community and our entire state. I know my dear friend Mike Puskar is looking down smiling that his beloved Mylan will now be part of the WVU family. I’m pleased WVU is taking this next step at the Viatris facility while also taking action to support former workers impacted by its closure,” Manchin said. “Investments in critical facilities like the Viatris property are essential to addressing our national security and public health, through improving our medical supply chain and increasing domestic manufacturing of medicines. As we move forward, I will continue working with WVU, Viatris and state and local officials to get the facility up and running and employing hardworking West Virginians.”
“The announcement that WVU and WVU Health are taking over the Viatris is welcome news for the Morgantown community and the entire state of West Virginia. I am glad to see WVU and WVU Health take this promising next step, and I wish them well in this new endeavor as they seek out new tenants. I know it has been a challenging time following the announcement regarding the facility, and I am glad we have the opportunity to move forward in a way to strengthen our economy and develop jobs in the area,” Capito said.
“Thank you to WVU for taking this necessary step to attract private investment and jobs,” McKinley said. “Losing Mylan was a blow to Morgantown and the surrounding area, but I am confident this facility can be put to good use again. We will continue to work with WVU, the state of West Virginia and all other stakeholders to provide more opportunity for West Virginia families.”
In December 2020 Viatris announced plans to close the Morgantown Mylan Chestnut Ridge oral solid dose manufacturing facility on July 31, 2021, eliminating the 1,500 jobs. The announcement came about two months after Viatris merged with Mylan Pharmaceuticals.
Original article written by Charles Young March 31, 2022, on wvnews.com